Sign in with Google. Opens in new tab
bullish
Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside
528 Views19 Apr 2023 04:18
Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »- Hygon/Sugon Merger: BIG Index Flows on Completion
- Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
- Holcim Spin-off (Amrize) Deep Dive
- HDB Financial IPO: The Investment Case
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Top Unpaywalled Insights
More »- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
- Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release31 Oct 2023
- Bikaji Foods IPO Lock-Up - Small Expiry with a Chance to Lift the Overhang09 May 2023
- Mankind Pharma IPO Trading - Strong Insti Demand Makes up for Retail Lag08 May 2023
- Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside19 Apr 2023
- Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag18 Apr 2023
- Mankind Pharma Pre-IPO - Thoughts on Valuations09 Feb 2023
- Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins08 Feb 2023
x